P3‐134: CIRCULATING METABOLITES ARE ASSOCIATED WITH WHITE MATTER HYPERINTENSITIES
作者
Hata Karamujić‐Čomić,Shahzad Ahmad,Dina Vojinović,Najaf Amin,Meike Willemijn Vernooij,Cornelia M. van Duijn,Thomas Hankemeier,Hieab H.H. Adams,Aad van der Lugt,M. Arfan Ikram,Daniël Bos,Cornelia M. van Duijn
Cerebral white matter hyperintensities (WMH) are associated with cognitive decline and dementia, including Alzheimer's disease (AD). Yet, the exact pathogenesis of WMH remains unclear. We addressed the question whether changes in circulating metabolites are associated with WMH. From the population-based Rotterdam Study and Erasmus Rucphen Family Study, 2949 participants (mean age 65.8 years) free of stroke or dementia were included in the present study. Blood samples from these participants were used to determine 150 metabolites by the nuclear magnetic resonance platform of Nightingale as part of BBMRI-NL and CoSTREAM consortium. All participants also underwent magnetic resonance imaging of the brain to evaluate and quantify WMH. Linear regression analysis was performed using natural log transformation of WMH volume as outcome of interest. We analyzed associations of the metabolites with WMH, while adjusting for sex, age, and age (model 1). Additionally, we adjusted for the use of lipid lowering medication (model 2). Finally, we correlated the metabolites associated to WMH to the known single nucleotide polymorphisms of WMH and AD. We found nominal evidence for associations between several lipoprotein subfraction components and WMH. Most notable associations were found for small low density lipoprotein cholesterol esters (P=8.8x10 in model 1) and small low density lipoprotein total cholesterol (P=8.9x10 in model 1). Certain associated metabolites were also associated with known genetic variants implicated in WMH. The strongest association was found for rs2984613 on 1q22. Also, the metabolites were associated with the APOE gene, the genetic driver of AD. Adjusting for APOE or rs2984613 did not alter the association of the lipid fractions to WMH, making it unlikely that the association is explained by confounding. We found evidence for pathophysiological involvement of low density lipoprotein subfraction components in the development of WMH. Extending the number of metabolites and studying these in larger cohorts may unravel additional underlying mechanisms in WMH.